Clinical trial
Modulation of Inflammatory Makers by the Supplementation of n7FA for 3 wk, Randomized Placebo Controlled Crossover Study
NCT03669575 is registered in ClinicalTrials.gov with Bastyr University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Modulation of Inflammatory Makers by the Supplementation of n7FA for 3 wk, Randomized Placebo Controlled Crossover Study
- Lead sponsor
- Bastyr University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 1, 2017
- Completion date
- October 1, 2019
- Enrollment
- 56 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.